Chronic inflammation is a significant healthcare problem in the world, substantially impacting patients’ quality of life and leading to life-threatening conditions. These conditions, if not prevented, ultimately lead to fatal diseases, such as cardiovascular diseases, diabetes and cancer, which contribute to three out of every five deaths worldwide and result in an estimated $90 billion of annual cost to the healthcare system in the United States.

The team at Evommune brings decades of combined knowledge, rising to meet this challenge head-on, across all stages of discovery and development. Their extensive R&D expertise in immunology, combined with first-hand experience shepherding novel agents through regulatory pathways, has already benefitted millions of patients.